Method for producing vectors containing a gene coding for an enzyme having reduced or deactivated feedback inhibition and the use thereof for producing amino acids and nucleotides
US-2015284760-A1 · Oct 8, 2015 · US
US11028384B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11028384-B2 |
| Application number | US-201816606230-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 13, 2018 |
| Priority date | May 18, 2017 |
| Publication date | Jun 8, 2021 |
| Grant date | Jun 8, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A DNA sequence that includes at least 70% identity with respect to SEQ ID NO: 1 and further includes a triplet at position 1027-1029 that codes for alanine.
Opening claim text (preview).
The invention claimed is: 1. An isolated DNA sequence encoding a pyruvate carboxylase, comprising: at least 97% identity with respect to SEQ ID NO: 1, wherein a triplet at position 1027-1029 codes for alanine. 2. The DNA sequence according to claim 1 , wherein the DNA has identity of at least 99% with respect to SEQ ID NO: 1. 3. The DNA sequence according to claim 1 , wherein the DNA sequence is a DNA according to SEQ ID NO: 1. 4. The DNA sequence according to claim 1 , further comprising, at position 3034-3036, a triplet which encodes for serine. 5. The DNA sequence according to claim 4 , wherein the DNA has identity of at least 97% with respect to SEQ ID NO: 2. 6. The DNA sequence according to claim 4 , wherein the DNA is according to SEQ ID NO: 2. 7. A pyruvate carboxylase having at least 97% identity with respect to a pyruvate carboxylase according to SEQ ID NO: 3, wherein alanine is present at position 343. 8. The pyruvate carboxylase according to claim 7 , wherein the pyruvate carboxylase has identity of at least 99% with respect to the pyruvate carboxylase according to SEQ ID NO: 3. 9. The pyruvate carboxylase according to claim 7 , wherein the pyruvate carboxylase is a pyruvate carboxylase according to SEQ ID NO: 3. 10. The pyruvate carboxylase according to claim 7 , further comprising serine at position 1012. 11. The pyruvate carboxylase according to claim 10 , wherein the pyruvate carboxylase has identity of at least 97% with respect to the pyruvate carboxylase according to SEQ ID NO: 4. 12. The pyruvate carboxylase according to claim 10 , wherein the pyruvate carboxylase is a pyruvate carboxylase according to SEQ ID NO: 4. 13. A vector, wherein the vector comprises a DNA sequence according to claim 1 . 14. The vector according to claim 13 , wherein the vector is a plasmid. 15. A microorganism, wherein the microorganism comprises a DNA sequence according to claim 1 . 16. The microorganism according to claim 15 , wherein the microorganism comprises a vector. 17. The microorganism according to claim 15 , wherein the microorganism is a microorganism selected from the group consisting of the genera Corynebacterium, Brevibacterium, Bacillus, Lactobacillus, Lactococcus, Candida, Pichia, Kluyveromyces, Saccharomyces, Escherichia, Zymomonas, Yarrowia, Methylobacterium, Ralstonia, Vibrio , and Clostridium. 18. A method for the production of products whose biosynthesis includes oxaloacetate as a precursor, the method comprising: fermenting a microorganism containing a DNA sequence according to claim 1 , which forms a pyruvate carboxylase, and performing an enrichment of the products in a medium or in cells. 19. The method according to claim 18 , wherein a product is isolated. 20. The method according to claim 18 , wherein a species from the group consisting of the genera Corynebacterium, Brevibacterium, Bacillus, Lactobacillus, Lactococcus, Candida, Pichia, Kluyveromyces, Saccharomyces, Escherichia, Zymomonas, Yarrowia, Methylobacterium, Ralstonia, Vibrio , and Clostridium is used as the microorganism. 21. The method according to claim 18 , wherein an amino acid of the aspartate family is produced. 22. The method according to claim 21 , wherein L-lysine, L-aspartate, L-asparagine, L-threonine, L-isoleucine, or L-methionine is produced. 23. The method according to claim 18 , wherein substances from the glutamate family of amino acids are produced, such as L-glutamate, glutamine, L-arginine, L-proline, L-citrulline, or L-ornithine; intermediates of the citrate cycle, such as malate, fumarate, succinate, malate, fumarate citrate, isocitrate, or 2-oxoglutarate; diamines, such as diaminopentane or diaminobutane; as well as further metabolites prepared from oxaloacetate, such itaconate, ectoine, gamma aminobutyrate, butanol, 1-propanol, L-citrulline, L-ornithine, D-arginine, or 4-hydroxyproline. 24. The method according to claim 18 , wherein the DNA sequence is more strongly expressed. 25. A chromosome including the DNA sequence according to claim 1 .
Bacterial isolates · CPC title
Genes encoding for enzymes or proenzymes · CPC title
Pyruvate carboxylase (6.4.1.1) · CPC title
Ligases (6) · CPC title
Phosphotransferases with a carboxyl group as acceptor (2.7.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.